4.8 Article

Structure reveals the activation mechanism of the MC4 receptor to initiate satiation signaling

Journal

SCIENCE
Volume 372, Issue 6544, Pages 808-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.abf7958

Keywords

-

Funding

  1. Abisch-Frenkel Foundation
  2. Minerva Stiftung Foundation
  3. Zuckerman STEM Leadership Program
  4. Ilse Katz Institute for Material Sciences and Magnetic Resonance Research
  5. Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly
  6. Joseph and Wolf Lebovic Lab
  7. Dov and Ziva Rabinovich Endowed Fund for Structural Biology
  8. Harmstieg New Scientist Fund
  9. Pearl Welinsky Merlo Foundation
  10. Glassman fellowship
  11. Israel Science Foundation (ISF) [1129/19]
  12. S. A. Schonbrunn Fellowship Fund
  13. Medical Research Council (MRC) UK/Academy of Medical Sciences Clinician Scientist Grant [G0802796]
  14. BBSRC [BB/R006946/1]
  15. MRC [MR/S008608/1]
  16. MRC doctoral training partnership
  17. MRC-Barts Charity iCase award [MRC0227]
  18. [CA18133]
  19. BBSRC [BB/R006946/1] Funding Source: UKRI
  20. MRC [MR/S008608/1] Funding Source: UKRI

Ask authors/readers for more resources

This study elucidated the mechanism of MC4R activation, identified a molecular switch for initiating satiation signaling, and suggested the involvement of calcium in agonist efficacy. These findings may guide the design of future weight-management drugs.
Obesity is a global epidemic that causes morbidity and impaired quality of life. The melanocortin receptor 4 (MC4R) is at the crux of appetite, energy homeostasis, and body-weight control in the central nervous system and is a prime target for anti-obesity drugs. Here, we present the cryo-electron microscopy (cryo-EM) structure of the human MC4R-Gs signaling complex bound to the agonist setmelanotide, a cyclic peptide recently approved for the treatment of obesity. The work reveals the mechanism of MC4R activation, highlighting a molecular switch that initiates satiation signaling. In addition, our findings indicate that calcium (Ca2+) is required for agonist, but not antagonist, efficacy. These results fill a gap in the understanding of MC4R activation and could guide the design of future weight-management drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available